These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2177768)

  • 1. Effect of sodium selenite and vitamin E treatment in myotonic dystrophy.
    Bäckman E; Henriksson KG
    J Intern Med; 1990 Dec; 228(6):577-81. PubMed ID: 2177768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy treated with selenium and vitamin E.
    Orndahl G; Selldén U; Hallin S; Wetterqvist H; Rindby A; Selin E
    Acta Med Scand; 1986; 219(4):407-14. PubMed ID: 3716883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study.
    Orndahl G; Grimby G; Grimby A; Johansson G; Wilhelmsen L
    J Intern Med; 1994 Mar; 235(3):205-10. PubMed ID: 8120515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium therapy of myotonic dystrophy.
    Orndahl G; Rindby A; Selin E
    Acta Med Scand; 1983; 213(3):237-9. PubMed ID: 6846068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of congenital myotonia with sodium selenite and vitamin E.
    Bäckman E; Henriksson KG
    J Intern Med; 1992 Oct; 232(4):376-7. PubMed ID: 1328462
    [No Abstract]   [Full Text] [Related]  

  • 6. Myotonia not aggravated by cooling. Force and relaxation of the adductor pollicis in normal subjects and in myotonia as compared to paramyotonia.
    Ricker K; Hertel G; Langscheid K; Stodieck G
    J Neurol; 1977 Aug; 216(1):9-20. PubMed ID: 72799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.
    Bäckman E; Nylander E; Johansson I; Henriksson KG; Tagesson C
    Acta Neurol Scand; 1988 Nov; 78(5):429-35. PubMed ID: 3218450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.
    Torres C; Moxley RT; Griggs RC
    J Neurol Sci; 1983 Jul; 60(1):157-68. PubMed ID: 6875612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dantrolene sodium in myotonic dystrophy.
    Mamoli B; Dal-Bianco P; Zeitlhofer K
    Eur Neurol; 1983; 22(1):29-34. PubMed ID: 6840139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine in the treatment of myotonia in myotonic dystrophy.
    Grant R; Sutton DL; Behan PO; Ballantyne JP
    J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):199-206. PubMed ID: 3553433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of selenium and vitamin E in boys with muscular dystrophy.
    Gamstorp I; Gustavson KH; Hellström O; Nordgren B
    J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antioxidant activity of ubiquinone-9 and its combinations with vitamin E and sodium selenite in toxic lesions of the liver].
    Vinogradova LF; Kharlitskaia EV; Mirzoian ZhA
    Farmakol Toksikol; 1989; 52(1):53-6. PubMed ID: 2540027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
    Airenne AL; Westermarck T
    Med Biol; 1984; 62(2):154. PubMed ID: 6471936
    [No Abstract]   [Full Text] [Related]  

  • 14. The changes in muscle strength and relaxation time after a comprehensive rehabilitation program for patients with myotonic dystrophy.
    Moon JH; Na YM; Kang SW; Lee HS
    Yonsei Med J; 1996 Aug; 37(4):237-42. PubMed ID: 8942293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological characterisation of the "warm up" effect of activity in patients with myotonic dystrophy.
    Cooper RG; Stokes MJ; Edwards RH
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1134-41. PubMed ID: 3225597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1.
    Bachasson D; Moraux A; Ollivier G; Decostre V; Ledoux I; Gidaro T; Servais L; Behin A; Stojkovic T; Hébert LJ; Puymirat J; Eymard B; Bassez G; Hogrel JY
    Neuromuscul Disord; 2016 Jul; 26(7):428-35. PubMed ID: 27234310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.
    Horáková M; Horák T; Parmová O; Bednařík J; Voháňka S
    Muscle Nerve; 2019 Apr; 59(4):431-435. PubMed ID: 30575988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.
    Finlay M
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):461-3. PubMed ID: 7045292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical involvement during myotonia in myotonic dystrophy: an fMRI study.
    Toth A; Lovadi E; Komoly S; Schwarcz A; Orsi G; Perlaki G; Bogner P; Sebok A; Kovacs N; Pal E; Janszky J
    Acta Neurol Scand; 2015 Jul; 132(1):65-72. PubMed ID: 25630356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of vitamin E and sodium selenite in experimental hepatic dystrophy].
    Skakun NP; Nesterovich IaM
    Farmakol Toksikol; 1977; 40(4):434-8. PubMed ID: 902744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.